Krystal Biotech Inc (KRYS)

Gross profit margin

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Gross profit (ttm) US$ in thousands 4,373 -40,772 -86,899 -91,693 -83,652 -75,835 -65,603 -55,240 -47,176 -40,433 -32,938 -27,946 -21,462 -13,729 -12,186 -9,063 -7,422 -6,502 -5,716 -5,183
Revenue (ttm) US$ in thousands 102,227 56,573 9,365 809 809 0 0 0 0 0 0 0 0 0 0 0 542 1,125 1,342 1,515
Gross profit margin 4.28% -72.07% -927.91% -11,334.12% -10,340.17% -1,369.37% -577.96% -425.93% -342.11%

March 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $4,373K ÷ $102,227K
= 4.28%

The gross profit margin of Krystal Biotech Inc has shown significant fluctuations over the reported periods, ranging from positive 4.28% to negative percentages as high as -11,334.12%. These variations indicate inconsistencies in the company's ability to generate profits from its sales after accounting for the cost of goods sold. The negative percentages suggest that the company may have experienced periods of incurring higher costs than revenue generated, leading to substantial losses in certain quarters. Further analysis of the underlying factors contributing to these extreme fluctuations is warranted to understand the financial performance of Krystal Biotech Inc more comprehensively.


Peer comparison

Mar 31, 2024